Company / Operating Margin
Orchestra BioMed Holdings, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-2437.5%
FY2025
5-year range
-2437.5% / -924.3%
FY2023-FY2025
Trend
-30.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -924.3% to -2437.5% over the past 2 years.
Based on SEC 10-K filings.
-2437.5% in FY2025.
Declined from -924.3% to -2437.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 30.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2437.5% | -30.6% |
| FY2024 | -1866.2% | -101.9% |
| FY2023 | -924.3% | - |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026